Circulation, Vol 64, 333-344, Copyright © 1981 by American Heart Association
RL Feldman, WW Nichols, CJ Pepine and CR Conti
The acute coronary hemodynamic and metabolic effects of intravenous
dipyridamole were studied in 13 patients. Total left ventricular (LV),
anterior (supplied by the left anterior descending coronary artery) and
inferior (supplied by circumflex and right coronary arteries) regional
flows and metabolic responses were assessed from the coronary sinus and
great cardiac vein. Perfusion to LV regions was classified as potentially
"normal" or "abnormal," based on coronary angiographic findings. Before
dipyridamole, coronary flow, LV oxygen delivery and lactate extraction in
both the normal and abnormal regions were similar. Within 1 minute after
injection of 20 mg of dipyridamole by i.v. bolus, total coronary flow
increased 51% (p less than 0.05). Fifteen minutes after injection the flow
increase persisted. Flow decreased to approximately control level by 20
minutes. The major component of this increased total coronary flow resulted
from increased flow in normal regions (75% at 1 minute, p less than 0.05).
Mean regional LV oxygen delivery and lactate extraction were not changed
significantly in either normal or abnormal regions. However, lactate
production occurred more often after dipyridamole in abnormal regions.
These results suggest that during dipyridamole-induced hyperemia, regional
coronary flow and metabolic responses depend upon the status of the
arteries supplying the LV region. Regional differences in flow and
metabolism occur independent of major changes in heart rate and aortic and
LV pressures.
ARTICLES
Acute effect of intravenous dipyridamole on regional coronary hemodynamics and metabolism
This article has been cited by other articles:
![]() |
J. E. Udelson, G. V. Heller, F. J.Th. Wackers, A. Chai, D. Hinchman, P. S. Coleman, V. Dilsizian, M. DiCarli, R. Hachamovitch, J. R. Johnson, et al. Randomized, Controlled Dose-Ranging Study of the Selective Adenosine A2A Receptor Agonist Binodenoson for Pharmacological Stress as an Adjunct to Myocardial Perfusion Imaging Circulation, February 3, 2004; 109(4): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Polad and L M Wilson Myocardial infarction during adenosine stress test Heart, February 1, 2002; 87 (2): e2 - e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosseel, P. Dendale, C. De Sadeleer, D. Schoors, P. Block, P.R. Franken, and M. Rosseel Dipyridamole-Induced Angina Pectoris During Sestamibi Stress Test in Patients with Significant Coronary Artery Disease: Clinical, Angiographic, and Nuclear Determinants Angiology, April 1, 1997; 48(4): 301 - 307. [Abstract] [PDF] |
||||
![]() |
O. Schillaci, M. Banci, F. Scopinaro, R. Tavolaro, G. Villotti, G. De Vincentis, F. Ventriglia, M. C. Borgia, A. Centi Colella, and V. Colloridi Myocardial Scintigraphy with 99mTc-Sestamibi in Children with Kawasaki Disease Angiology, November 1, 1995; 46(11): 1009 - 1014. [Abstract] [PDF] |
||||
![]() |
T. Konishi, T. Koyama, T. Aoki, Y. Futagami, and T. Nakano Dipyridamole Radionuclide Ventriculography in Patients with Coronary Artery Disease: Comparison with Ergometer Exercise Angiology, July 1, 1990; 41(7): 518 - 524. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1981 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |